News
ReveraGen BioPharma receives National Institutes of Health ethics grant to return data to participants in vamorolone clinical trials
Rockville MD, 22 October 2019
The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (USA) has awarded an ethics research grant to ReveraGen BioPharma to return patient-level and aggregate data to